(Q38020227)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22716185%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Psoriasis: rationale for targeting interleukin-17 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22716185%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22716185%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

G Girolomoni

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22716185%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

U Mrowietz

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22716185%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

1 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22716185%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Dermatology

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22716185%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22716185%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22716185%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

717-724

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22716185%20AND%20SRC:MED&resulttype=core&format=json

Prevalence and treatment of psoriasis in the United Kingdom: a population-based study.

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Epidemiology of psoriasis. Review and the German perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Quality of life in patients with psoriasis: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Definition of treatment goals for moderate to severe psoriasis: a European consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

The burden of psoriasis in Canada: insights from the pSoriasis Knowledge IN Canada (SKIN) survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Why statistics matter: limited inter-rater agreement prevents using the psoriasis area and severity index as a unique determinant of therapeutic decision in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Impact of comorbidities on the management of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Usefulness of the framingham risk score in patients with chronic psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Psoriasis genetics: breaking the barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Identification of low-frequency TRAF3IP2 coding variants in psoriatic arthritis patients and functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Psoriasis: from pathogenesis to novel therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Innate immunity and antimicrobial defense systems in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Interleukin-17 and type 17 helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Structure and signalling in the IL-17 receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

The IL-17 family cytokines in immunity and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Interleukin-17 family and IL-17 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

IL-17 and IL-22: siblings, not twins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Functional specialization of interleukin-17 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

IL-23 drives pathogenic IL-17-producing CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Identification of a novel proinflammatory human skin-homing Vγ9Vδ2 T cell subset with a potential role in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Emerging role of IL-17 in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Interleukin 17 in vascular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Interleukin-17 and lung host defense against Klebsiella pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Innate IL-17-producing cells: the sentinels of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11099.X

Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling

21 January 2018

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI40202

Identifiers

DOI

10.1111/J.1365-2133.2012.11099.X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22716185%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference